...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Epigenetic Therapeutic Targets Virtual Summit Presentation July 28, 2020

On July 28, 2020, Resverlogix participated in the Epigenetic Therapeutic Targets Virtual Summit, with an oral presentation by Dr. Norman Wong, titled: "Selective Bromodomain Inhibition with the Bromodomain and Extraterminal Domain (BET) Inhibitor Apabetalone: Discovery to Phase 3 Cardiovascular Outcomes Study." Presentation can be accessed here.

https://www.resverlogix.com/upload/media_element/215/a92c88143fe9/2020-07-28-epigenetic-therapeutic-targets---wong.pdf

Share
New Message
Please login to post a reply